MedTrace Logo

Risk Profile for Patients With Atrial Fibrillation

NCT01510210 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2023-11-29

No results posted yet for this study

Summary

The objective of this study is to assess the risk profile in patients with atrial fibrillation, which represents the degree of changes in the atrial tissue and which can help predict in which patients rhythm control will be successful. This risk profile will consist of a combination of underlying (heart) disease and risk factors, measurements obtained from echocardiograms, and circulating biomarkers. Ultimately this risk profile can be used to guide type of rhythm control therapy in individual patients with atrial fibrillation.

Conditions

Sponsors & Collaborators

  • Netherlands Heart Foundation

    collaborator OTHER

  • I.C. Van Gelder

    lead OTHER

Principal Investigators

  • Harry Crijns, MD PhD · Maastricht University Medical Center

  • Isabelle C Van Gelder, MD PhD · University Medical Center Groningen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2025-03-31
Completion
2025-03-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01510210 on ClinicalTrials.gov